SAN DIEGO, Aug. 4 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that it recently has been granted seven additional patents by the U.S. and European patent authorities that extend the Company’s intellectual property estate related to automated instrument systems for nucleic acid testing (NAT).
